| EPE056 | High mean weight gain among patients on Dolutegravir in Malawi | E-poster | Implementation science of scaling up HIV treatment |
| PESUD28 | High linkage to treatment among key populations who self-test through a peer HIV self-test distribution and community-based ART program among key populations in Lagos, Nigeria | Poster exhibition | Community-based approaches (including empowerment, outreach and service delivery) |
| EPB248 | High levels of non-nucleoside reverse transcriptase inhibitor (NNRTI) pre-treatment HIV drug resistance (PDR) in Zambia: results from the national survey | E-poster | Resistance to ART |
| EPB253 | High levels of Acquired HIV Drug Resistance (ADR) among HIV positive Zambian adults with HIV treatment failure: results from the national ADR survey | E-poster | Resistance to ART |
| EPC087 | High incidence of HIV and STIs in late pregnancy: compelling evidence for repeat etiological testing | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
| OAC0403 | High HIV incidence and mortality in a multi-site cohort of transgender women in the eastern and southern United States | Oral abstract session with live Q&A | Epidemiology of HIV in key populations (e.g., gay men and other men who have sex with men, sex workers, transgender people, people who inject rugs and prisoners and other incarcerated people)) |
| EPB245 | High drug resistance levels compromise the control of HIV infection in paediatric and adult populations in Bata, Equatorial Guinea | E-poster | Resistance to ART |
| EPE006 | High demand for HIV pre-exposure prophylaxis (PrEP) services amongst key populations in Sierra Leone: early lessons from the country's first PrEP program | E-poster | Implementation science of scaling up prevention (including PrEP) |
| EPA070 | High adaptive NK cell frequencies reduce the risk of developing coronary atherosclerotic plaque in cytomegalovirus infected people living with HIV | E-poster | HIV and co-morbidities |
| PESAB03 | High accuracy of an enzyme-linked immunoasssay for detection of tenofovir alafenamide: implications for point-of-care antiretroviral adherence monitoring | Poster exhibition | Adherence testing |